1. Enheten
  2. Ansatte
  3. Hallvard Lilleng
No picture, placeholder image
No picture, placeholder image
Førsteamanuensis II Institutt for klinisk medisin hallvard.lilleng@uit.no Tromsø

Hallvard Lilleng

  • 1
    Sara Cecilie Staubo, Ole Martin Fuskevåg, Mathias Toft, Ingeborg Haugesag Lie, Kirsti Margrete Johansen Alvik, Pål Jostad m.fl.:
    Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease
    Journal of Neurology 2025 DOI / ARKIV
  • 1
    Svein Ivar Bekkelund, Karin Louise Abeler, Hallvard Lilleng, Sissel Løseth :
    A case control study of the relationship between persistent serum creatine kinase elevation and polyneuropathy
    Scientific Reports 2024 DOI / ARKIV
  • 1
    Sara Cecilie Staubo, Ole Martin Fuskevåg, Mathias Toft, Ingeborg Haugesag Lie, Kirsti Margrete Johansen Alvik, Pål Jostad m.fl.:
    Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease
    European Journal of Neurology 2023 DOI / ARKIV / ARKIV
  • 1
    Stein Harald Johnsen, Hallvard Lilleng, Svein Ivar Bekkelund :
    Creatine Kinase as Predictor of Blood Pressure and Hypertension. Is It All About Body Mass Index? A Follow-Up Study of 250 Patients
    The Journal of Clinical Hypertension 2014 DOI / ARKIV
  • 1
    Hallvard Lilleng, Karin Louise Abeler, Stein Harald Johnsen, Eva Stensland, Sissel Løseth, Sigurd Lindal m.fl.:
    Clinical impact of persistent hyperCKemia in a Norwegian general population: A case-control study
    Neuromuscular Disorders 2013 DOI / ARKIV
  • 1
    Hallvard Lilleng, Stein Harald Johnsen, Tom Wilsgaard, Svein Ivar Bekkelund :
    Are the currently used reference intervals for creatine kinase (CK) reflecting the general population? The Tromso Study
    Clinical Chemistry and Laboratory Medicine 2012 DOI / ARKIV
  • 1
    stein harald Johnsen, Hallvard Lilleng, Tom Wilsgaard, Svein Ivar Bekkelund :
    Creatine kinase activity and blood pressure in a normal population: the Tromso study
    Journal of Hypertension 2011 DOI / ARKIV
  • 1
    Hallvard Lilleng, Karin Louise Abeler, Stein Harald Johnsen, Eva Stensland, Sissel Løseth, Rolf Jorde m.fl.:
    Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromso Study
    Neuromuscular Disorders 2011 DOI / ARKIV
  • 1
    Hallvard Lilleng, Svein Ivar Bekkelund :
    Arctic environment triggers migraine attacks
    Canadian Family Physician (CFP) 2010 ARKIV
  • 1
    Hallvard Lilleng, Svein Ivar Bekkelund :
    Seasonal Variation of Migraine in an Arctic Population
    Headache 2009 DOI / ARKIV
  • Stein Harald Johnsen, Hallvard Lilleng, Svein Ivar Bekkelund :
    Reply: Creatine kinase, overweight, and hypertension-The issue is more complex than we thought
    The Journal of Clinical Hypertension 2015 DOI / ARKIV
  • Hallvard Lilleng, Karin Louise Abeler, Stein Harald Johnsen, Eva Stensland, S Loseth, Sigurd Lindal m.fl.:
    Clinical impact of persistent hyperCKemia in a Norwegian general population: a case-control study
    European Journal of Neurology 2012 ARKIV
  • Stein Harald Johnsen, Hallvard Lilleng, Svein Ivar Bekkelund :
    Is the association between creatine kinase and blood pressure causal?
    Journal of Hypertension 2011 DOI / ARKIV
  • Hallvard Lilleng, stein harald Johnsen, Eva Stensland, K Abeler, Sissel Løseth, Rolf Jorde m.fl.:
    Creatine kinase (CK) in a normal population: Towards new referent values?
    Neuromuscular Disorders 2009 DOI / ARKIV
  • Hallvard Lilleng, Eva Stensland, stein harald Johnsen, K Abeler, Sissel Løseth, Rolf Jorde m.fl.:
    Prevalence of hyperCKemia in a normal population
    European Journal of Neurology 2009 ARKIV

    • De 50 siste resultatene vises på siden. Se alle arbeider i NVA her →